IntegenX, Inc. designs, manufactures, and markets automation systems that enable reliable microsample preparation and analysis for the life sciences. It offers Apollo 100, a platform that allows the processing of DNA sequencing reactions; Apollo 200, an integrated sample preparation system for human DNA identification; microfluidics for DNA sequencing, molecular diagnostics, and human identification applications; and Apollo 324 system, a benchtop robotic workstation that automates the construction of DNA fragment libraries for next-generation sequencing. The company was formerly known as Microchip Biotechnologies, Inc. and changed its name to IntegenX, Inc. in March 2010. The company was incorporated in 2003 and is based in Pleasanton, California.
Current Team (6)Update
Funding Rounds (4) - $78.2MUpdate
SVIC identifies and invests in promising start-up companies. They are strongly committed to...
Venture capital Firm
Venture Capital Firm
VC firm (expansion and late stage)
Founded in 1985, Domain Associates, L.L.C. is a venture capital firm with an exclusive focus on...
Essex Woodlands was founded in 1985 with the establishment of Essex Venture Fund I, LP. Since...
In-Q-Tel identifies and partners with companies developing cutting-edge technologies to help...
5720 Stoneridge Drive
Pleasanton, CA 94588